Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Searle uses Epimmune technologies to develop cancer therapies

March 4, 1998

Status of Oncolym updated

March 4, 1998

Select Therapeutics licenses cancer-related technology

March 3, 1998

Cell Pathways/U. of Arizona study compounds for precancerous lesions

March 3, 1998

Penclomedine metabolite shows comparable anticancer efficacy, reduced neurotoxicity

March 3, 1998

Takeda exercises option to develop therapeutic protein

March 3, 1998

New compound for mucositis in development at Alizyme

March 2, 1998

LXR and Copernicus establish cancer gene therapy collaboration

March 2, 1998

Bristol-Myers Squibb developing new paclitaxel derivatives

March 2, 1998

Improved treatment outlook for children with leukemia?

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...